LP3 Network Free Webinar - Veterinary Compounding, A Customized Approach

Download in electronic PDF format for $25



Search the Complete Journal Archives

In Vitro Studies on the Release of Morphine Sulfate from Compounded Slow-Release Morphine-Sulfate Capsules

Author(s):  Webster Kathy D, Al-Achi Antoine, Greenwood Robert

Issue:  Sep/Oct 1999 - Natural Hormone Replacement Therapy
View All Articles in Issue

Abstract:  Morphine sulfate is a commonly prescribed drug for the relief of pain. This study investigated the dissolution profile of extemporaneously prepared slow-release morphine-sulfate capsules and MS Contin® (Purdue Frederick, Norwalk, CT). Extemporaneously prepared capsules obtained from one pharmacist were compared with MS Contin tablets. In addition, we compared capsules prepared by 15 different pharmacists and three different batches prepared by the same pharmacist. A dissolution test1 was used to generate the dissolution profile for drug products. The compounded capsules demonstrated a slow-release profile that was similar to the commercial preparation except that the morphine sulfate was released at a faster rate. The zero-order dissolution rate constant (k0, milligrams/ hour) was calculated from the dissolution profiles. Statistical analysis of k0 showed that capsules prepared extemporaneously by pharmacist one showed a faster dissolution compared to MS Contin (p=0.0368); the difference was a rate of 0.81 mg/hour during the first four hours. When variability among compounding pharmacists was compared, only one batch of compounded capsules prepared from 15 different pharmacies showed a significantly different rate of morphine release. When reproducibility by a single pharmacist was examined, capsules showed some variation from batch to batch (p=0.05). Although variation was seen from one pharmacy to another and even between different batches made by the same pharmacist, the compounded capsules showed a remarkably consistent in vitro slow-release profile.

Related Keywords: dissolution, morphine sulfate, MS Contin, pain, slow release

Related Categories: PAIN MANAGEMENT, PEER-REVIEWED

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
In Vitro Studies on the Release of Morphine Sulfate from Compounded Slow-Release Morphine-Sulfate Capsules Webster Kathy D, Al-Achi Antoine, Greenwood Robert Sep/Oct 1999 409-411 Buy
Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release Bogner Robin H, Szwejkowski Jessica, Houston Alana Sep/Oct 2001 401-405 Buy
In Vitro Evaluation of Extemporaneously Compounded Slow-Release Capsules Containing Morphine Sulfate or Oxycodone Hydrochloride Glowiak Dana L, Green Julie L, Bowman Bill J Mar/Apr 2005 157-164 Buy
Physical and Chemical Stability of Low and High Concentrations of Morphine Sulfate with Clonidine Hydrochloride Packaged in Plastic Syringes Xu Quanyun A, Trissel Lawrence A, Pham Lien Jan/Feb 2002 66-69 Buy
Physical and Chemical Stability of Low and High Concentrations of Morphine Sulfate with Bupivacaine Hydrochloride Packaged in Plastic Syringes Trissel Lawrence A, Xu Quanyun A, Pham Lien Jan/Feb 2002 70-73 Buy
Custom-Compounded Micronized Hormones in a Slow-Release Capsule Matrix Timmons Evelyn D, Timmons Steven P Sep/Oct 2002 378 Buy
Compounding Slow-release Capsules: A Comprehensive Review and an Excel Spreadsheet for Faster Calculation of Excipients Zur Eyal Jan/Feb 2013 10-22 Buy
Morphine Sulfate Slow-Release Suppositories Allen Loyd V Jr Jan/Feb 1997 32-33 Buy
Compounding of Slow-release Niacinamide Capsules: Feasibility and Characterization Radojkovic Branko, Milic Jela, Calija Bojan Sep/Oct 2012 434-437 Buy
Calculations Prince Shelly J Jul/Aug 2003 294 Buy